CD26 Antigen and HIV Fusion?
- 20 May 1994
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 264 (5162) , 1159-1160
- https://doi.org/10.1126/science.7909960
Abstract
Nanometer-scale layered structures based on thallium(III) oxide were electrodeposited in a beaker at room temperature by pulsing the applied potential during deposition. The conducting metal oxide samples were superlattices, with layers as thin as 6.7 nanometers. The defect chemistry was a function of the applied overpotential: High overpotentials favored oxygen vacancies, whereas low overpotentials favored cation interstitials. The transition from one defect chemistry to another in this nonequilibrium process occurred in the same potential range (100 to 120 millivolts) in which the rate of the back electron transfer reaction became significant. The epitaxial structures have the high carrier density and low electronic dimensionality of high transition temperature superconductors.Keywords
This publication has 7 references indexed in Scilit:
- HIV-2 and SIV Infection of Nonprimate Cell Lines Expressing Human CD4: Restrictions to Replication at Distinct StagesVirology, 1994
- T Cell Activation Antigen, CD26, as a Cofactor for Entry of HIV in CD4 + CellsScience, 1993
- Effect of Mutations in the V3 Loop of HIV-1 gp120 on Infectivity and Susceptibility to Proteolytic CleavageAIDS Research and Human Retroviruses, 1993
- Specific cell surface requirements for the infection of CD4-positive cells by human immunodeficiency virus types 1 and 2 and by simian immunodeficiency virusVirology, 1991
- The V3 Loops of the HIV-1 and HTV-2 Surface Glycoproteins Contain Proteolytic Cleavage Sites: A Possible Function in Viral Fusion?AIDS Research and Human Retroviruses, 1991
- Replication of HIV-1 in a wide variety of animal cells following phenotypic mixing with murine retrovirusesVirology, 1990
- Receptor interference groups of 20 retroviruses plating on human cellsVirology, 1990